SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-19-006371
Filing Date
2019-08-23
Accepted
2019-08-23 17:03:15
Documents
3
Period of Report
2019-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_082019.htm 8-K 41860
2 PURCHASE AGREEMENT ex10-01.htm EX-10.01 347687
3 REGISTRATION RIGHTS AGREEMENT ex10-02.htm EX-10.02 119302
  Complete submission text file 0001387131-19-006371.txt   510130
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 191049810
SIC: 2834 Pharmaceutical Preparations